| Company Name: |
Sigma-Aldrich |
| Tel: |
021-61415566 800-8193336 |
| Email: |
orderCN@merckgroup.com |
|
| | Aurora Kinase Inhibitor III Basic information |
| Product Name: | Aurora Kinase Inhibitor III | | Synonyms: | Aurora Kinase Inhibitor III;Cyclopropanecarboxylic acid {3-[4-(3-trifluoromethyl-phenylamino)-pyrimidin-2-ylamino]-phenyl}-amide;N-[3-[[4-[3-(trifluoromethyl)anilino]pyrimidin-2-yl]amino]phenyl]cyclopropanecarboxamide;AKI-7169;Aurora Kinase Inhibitor III - CAS 879127-16-9 - Calbiochem;Aurora Kinase Inhibitor 3;Cyclopropanecarboxamide, N-[3-[[4-[[3-(trifluoromethyl)phenyl]amino]-2-pyrimidinyl]amino]phenyl]-;Cyclopropanecarboxylic acid {3-[4-(3-trifluoromethyl-phenylamino)-pyrimidin-2-ylamino]-phenyl}-amide >=98% (HPLC), solid | | CAS: | 879127-16-9 | | MF: | C21H18F3N5O | | MW: | 413.4 | | EINECS: | | | Product Categories: | | | Mol File: | 879127-16-9.mol |  |
| | Aurora Kinase Inhibitor III Chemical Properties |
| density | 1.456±0.06 g/cm3(Predicted) | | storage temp. | 2-8°C | | solubility | H2O: <2mg/mL | | pka | 14.51±0.70(Predicted) | | form | White solid | | color | white | | Water Solubility | H2O: <2mg/mL
DMSO: >7mg/mL | | InChI | 1S/C21H18F3N5O/c22-21(23,24)14-3-1-4-15(11-14)26-18-9-10-25-20(29-18)28-17-6-2-5-16(12-17)27-19(30)13-7-8-13/h1-6,9-13H,7-8H2,(H,27,30)(H2,25,26,28,29) | | InChIKey | RDTDWGQDFJPTPD-UHFFFAOYSA-N | | SMILES | FC(F)(F)c1cccc(Nc2ccnc(Nc3cccc(NC(=O)C4CC4)c3)n2)c1 |
| WGK Germany | 3 | | Storage Class | 13 - Non Combustible Solids |
| | Aurora Kinase Inhibitor III Usage And Synthesis |
| Uses | Aurora kinase inhibitor-3 is a strong and selective Aurora A kinase inhibitor with an IC50 of 42 nM, and weakly inhibits EGFR with an IC50 of >10 μM. Aurora kinase inhibitor-3 has a binding mode with the cyclopropanecarboxylic acid moiety directed towards the solvent exposed region of the ATP-binding pocket[1]. | | General Description | A cell-permeable 2,4-dianilinopyrimidine compound that acts as an ATP-competitive, potent, but non-selective inhibitor of Aurora A (IC50 = 42 nM). At higher concentrations, also inhibits the activities of other kinases, such as Lck, Bmx, IGF-1R, and Syk (IC50 = 131, 386, 591, and 887 nM, respectively). | | Biochem/physiol Actions | Target IC50: 42 nM against Aurora A; 131, 386, 591, and 887 nM, against Lck, Bmx, IGF-1R, and Syk , respectively | | IC 50 | Aurora A: 42 nM (IC50) | | References | [1] Tari LW, et al. Structural basis for the inhibition of Aurora A kinase by a novel class of high affinitydisubstituted pyrimidine inhibitors. Bioorg Med Chem Lett. 2007 Feb 1;17(3):688-91. DOI:10.1016/j.bmcl.2006.10.086 |
| | Aurora Kinase Inhibitor III Preparation Products And Raw materials |
|